Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient

Condition:   Hepatitis B Virus Interventions:   Biological: Human Serum Albumin/interferon alpha2b fusion protein;   Biological: Pegasys Sponsor:   Tianjin SinoBiotech Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials